supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Cannabinoids
drug:
Etorphine
Research Papers that Mention the Interaction
“This asymmetric cross-desensitization coincided with asymmetric cross downregulation: etorphine downregulated the binding of the cannabinoid ligand [3H]CP55,940, while DALN failed to reduce the binding of the opioid ligand [3H]diprenorphine.”
Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation“In addition, asymmetric cross-desensitization was found: while long-term exposure to DALN induced homologous desensitization, and did not reduce the effect of etorphine, long-term exposure to etorphine attenuated the cannabinoid activation of G-proteins.”
Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback